Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990 Nov;81(11):1711-9.
doi: 10.5980/jpnjurol1989.81.1711.

[Study on nucleolar organizer regions in bladder neoplasm]

[Article in Japanese]
Affiliations
Free article

[Study on nucleolar organizer regions in bladder neoplasm]

[Article in Japanese]
T Takeuchi. Nihon Hinyokika Gakkai Zasshi. 1990 Nov.
Free article

Abstract

Quantification of the argyrophilic nucleolar organizer regions (AgNORs), using a one-step silver colloid method, was made in proliferative urothelial lesions including neoplasm of the rat urinary bladder induced by 0.05% N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) and of the human urinary bladder. The mean numbers of AgNORs in various experimental lesions in rats given BBN for 5-30 weeks in drinking water were: nontreated urothelium (n = 6), 1.26 +/- 0.09; urothelium outside focal lesions (n = 10), 1.75 +/- 0.10; simple hyperplasia (n = 10), 2.01 +/- 0.15; papillary or nodular (PN) hyperplasia (n = 10), 2.15 +/- 0.19; papilloma (n = 5), 2.37 +/- 0.12; and transitional cell carcinoma (TCC) (n = 5), 3.52 +/- 0.23. There was a significant difference in the mean number of AgNORs between any two groups (p less than 0.05), except for simple hyperplasia vs PN hyperplasia (p = 0.085). In various proliferative lesions of human biopsy and resected samples, the mean numbers of AgNORs were normal urothelium (n = 8), 1.71 +/- 0.08; proliferative cystitis (n = 14), 1.79 +/- 0.18; hyperplasia (n = 8), 1.76 +/- 0.23; mild dysplasia (n = 5), 2.15 +/- 0.36; moderate dysplasia (n = 13), 2.61 +/- 0.27; severe dysplasia (n = 6), 3.46 +/- 0.57; G0 of TCC (n = 9), 1.95 +/- 0.17; G1 of TCC (n = 16), 2.39 +/- 0.20; G2 of TCC (n = 21), 3.33 +/- 0.31; G3 of TCC (n = 15), 4.68 +/- 0.51; and carcinoma in situ of TCC (n = 10), 3.61 +/- 0.52.(ABSTRACT TRUNCATED AT 250 WORDS)

PubMed Disclaimer

Similar articles

Publication types